Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1955 2
1963 1
1964 1
1965 2
1966 1
1967 1
1968 2
1969 1
1970 5
1973 5
1974 1
1975 1
1976 1
1978 2
1980 1
1981 2
1982 2
1983 1
1984 4
1986 4
1987 5
1988 1
1989 3
1990 1
1992 4
1993 5
1994 2
1995 8
1996 9
1997 7
1998 11
1999 15
2000 10
2001 3
2002 5
2003 4
2004 7
2005 4
2006 10
2007 9
2008 6
2009 5
2010 17
2011 10
2012 9
2013 19
2014 19
2015 6
2016 7
2017 2
2018 2
2019 4
2020 3
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

262 results
Results by year
Filters applied: . Clear all
Page 1
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M; West Japan Oncology Group. Mitsudomi T, et al. Among authors: asami k. Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.
262 results